Mass poisoning with NPS: 2C-E and Bromo-DragonFly.
Stefanie Iwersen-Bergmann, S Lehmann, A Heinemann, C Schröder, Alexander Müller, Hilke Jungen, Hilke Andresen-Streichert, K Pueschel, C Vidal, K Mercer-Chalmers-Bender
International Journal of Legal Medicine 2019 DOI: 10.1007/s00414-018-1882-9 (opens in new tab)
The journal has published a correction to this paper. Read the correction (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case series Case report Peer reviewed |
|---|---|
| Sample size | 29 |
| Population | Middle-aged adults (24–56 years old) hospitalized after mass poisoning at an esoteric weekend seminar |
| Keywords | 2c-e Bromo-dragonfly Concentration Mass poisoning Confirmed the presence Blood samples Urine samples |
| Citations | 20 |
| Key findings | BDF was confirmed in all urine samples and 17 blood samples, while 2C-E was detected only in urine, underscoring the need for urine sampling in suspected NPS intoxications. |
Abstract
Reports of intoxications with new psychoactive substances (NPS) mostly involve young people, as they are the main consumers of these types of drugs. This report centers on a case that was unusual due to it being a mass-poisoning event involving middle-aged individuals who had consumed a combination of the two different new psychoactive drugs 2,5-dimethoxy-4-ethylphenethylamine (2C-E) and 1-(8-bromofuro[2,3-f][1]benzofuran-4-yl)-2-propanamine (Bromo-DragonFly, BDF). The mass poisoning of 29 individuals (24-56 years old) resulted in their admission to six different hospitals with severe symptoms of intoxication. All symptoms manifested after consumption of an unknown drug formulation around lunchtime during an esoteric weekend seminar. Urine (n = 11) and blood samples (n = 29), collected from the 29 individuals for police investigation, were analyzed with immunochemical techniques, GC/MS and LC-MS/MS. 2C-E was confirmed in seven urine samples, but not in blood. BDF was confirmed in all urine samples, and in 17 blood samples. The blood samples exhibited BDF concentrations between ca. 0.6 and ca. 2.0 μg/L, while urine concentrations of BDF ranged from ca. 1.6 to 35 μg/L. The concentration of 2C-E in urine was found to be between ca. 1.5 and 183 μg/L. All patients made a complete recovery, although some had required mechanical ventilation. The investigation and the presentation of this case illustrates not only mass intoxication with 2C-E and BDF, with corresponding blood and urine concentrations, but also the necessity of collecting urine samples in cases where NPS-consumption is suspected, in order to improve the chances of analytical detection.
Citations in the library
Cited by 11
- Designer drugs: mechanism of action and adverse effects Archives of Toxicology April 1, 2020
- Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review Journal of Analytical Toxicology April 20, 2022
- Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics Experimental Neurology June 4, 2021
- In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor Archives of Toxicology July 5, 2020
- Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances Analytical Chemistry November 14, 2019
and 6 more in the library
Cites 7
- Clinical toxicology of newer recreational drugs Clinical Toxicology October 1, 2011
- Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly Current reviews in clinical and experimental pharmacology May 1, 2011
- Enantiospecific Synthesis and Pharmacological Evaluation of a Series of Super-Potent, Conformationally Restricted 5-HT2A/2C Receptor Agonists Journal of Medicinal Chemistry January 26, 2001
- “Not for Human Consumption”: A Review of Emerging Designer Drugs Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy April 8, 2014
- A Novel (Benzodifuranyl)aminoalkane with Extremely Potent Activity at the 5-HT2A Receptor Journal of Medicinal Chemistry December 1, 1998
and 2 more in the library